David Rickey, Director at CYTORI THERAPEUTICS, INC. (CYTX), bought 30,000 shares at $2.32 ($70K) on 2014-06-05, disclosed to the SEC on 2014-06-09.
Open-market purchase of $70k CYTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.32 | 66 | $153 | 0.2% |
| 2 | $2.32 | 134 | $311 | 0.4% |
| 3 | $2.33 | 10,282 | $24K | 34.2% |
| 4 | $2.33 | 5,139 | $12K | 17.1% |
| 5 | $2.34 | 3,827 | $9K | 12.8% |
| 6 | $2.34 | 7,652 |
| $18K |
| 25.6% |
| 7 | $2.35 | 968 | $2K | 3.2% |
| 8 | $2.35 | 1,932 | $5K | 6.5% |
| Total | $2.34 avg | 30,000 | $70K | 100% |
| Filing → |
| CYTX | BUY | 2015-08-31 | $17K | — | Filing → |
| CYTX | BUY | 2015-08-28 | $23K | — | Filing → |
| CYTX | BUY | 2015-08-24 | $19K | — | Filing → |